Of the 22 genes upregulated in human LSCs, only low-density lipoprotein receptor (LDLR) and SLC6A6 were significantly associated with poor prognosis in AML (Fig. 2a–c and Extended Data Fig. 4a,b). The gene discussed is SLC6A6; the disease is acute myeloid leukemia.